Endpoints News 4 juin 2026 Acting FDA commissioner pledges to prevent political interference in rare disease meeting
Endpoints News 4 juin 2026 Dimension seeks up to $750M for third life sciences fund after string of success
Endpoints News 4 juin 2026 Mammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again
Endpoints News 4 juin 2026 Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic